Drug Profile
MRX 34
Alternative Names: miR-34 - Synlogic; miR-34 mimic - Synlogic; MRX-01; MRX34Latest Information Update: 08 Apr 2021
Price :
$50
*
At a glance
- Originator Asuragen
- Developer Cancer Prevention & Research Institute of Texas; Mirna Therapeutics
- Class Antineoplastics; MicroRNAs
- Mechanism of Action Tumour suppressor gene modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Haematological malignancies; Liver cancer; Non-small cell lung cancer; Solid tumours